Webinars
Novel designer benzodiazepines (DBZD) and novel synthetic opioids (NSO) continue to emerge on the illicit novel psychoactive substance (NPS) market. Given this trend, and the continuing rise in benzodiazepine prescriptions, the likelihood for benzodiazepines to appear in toxicological samples alongside synthetic opioids is high. Understanding the synthesis and analytical interpretation of both NPS classes can help prepare forensic toxicologists for the appearance of unknown compounds in their casework.
Join Nathan Layle and Becca Boyce, synthetic organic chemists at Cayman Chemical, as they present the results of our in-house human liver microsome (HLM) studies and demonstrate how these findings can be applied to new analogs. Attendees will gain insights into emerging compounds and metabolites that may soon appear in forensic casework.
Presented as part of the CFSRE's 2026 Current Trends in Forensic Toxicology Symposium.
Do you have a question or comment for the presenter? Let us know.